How Private Equity Gets Its Cut from Medicare Advantage

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The report analyzes private equity's involvement in the multibillion-dollar Medicare Advantage sector, noting a peak in deal activity in 2021 followed by a slowdown due to interest rates and tighter regulations. It warns that private equity ownership in healthcare can lead to anticompetitive consolidation, fraud, and cost-cutting that harms patients and workers, and recommends policies such as joint liability for owners and increased regulatory scrutiny of deals.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • Private equity firms have actively invested in the Medicare Advantage ecosystem between 2016 and 2023, with a particular focus on the senior insurance distribution market, including brokerage and marketing firms. Deal activity peaked in 2021, which may have been influenced by regulatory rollbacks on marketing implemented by CMS during the Trump administration.
  • Investment activity in the sector has decreased since 2021, a trend attributed to a shifting regulatory environment under the Biden administration—which includes tighter marketing regulations and proposed payment limits for brokers—as well as rising interest rates.
  • Private equity ownership in healthcare presents systemic risks, including the potential for Medicare and Medicaid fraud, anticompetitive consolidation that increases costs, and the use of high debt levels that force cost-cutting at the expense of workers and patients.

Cite the original document

APA
Private Equity Stakeholder Project (2024). How Private Equity Gets Its Cut from Medicare Advantage. https://pestakeholder.org/reports/how-private-equity-gets-its-cut-from-medicare-advantage/
Chicago
Private Equity Stakeholder Project. How Private Equity Gets Its Cut from Medicare Advantage. 2024. https://pestakeholder.org/reports/how-private-equity-gets-its-cut-from-medicare-advantage/.
Wikipedia
{{cite report |author=Private Equity Stakeholder Project |title=How Private Equity Gets Its Cut from Medicare Advantage |date=13 February 2024 |url=https://pestakeholder.org/reports/how-private-equity-gets-its-cut-from-medicare-advantage/ |access-date=23 October 2026 |via=Climate Insights Directory}}
BibTeX
@techreport{privateequitystakeholderproject2024how, author = {{Private Equity Stakeholder Project}}, title = {{How Private Equity Gets Its Cut from Medicare Advantage}}, institution = {Private Equity Stakeholder Project}, year = {2024}, month = feb, url = {https://pestakeholder.org/reports/how-private-equity-gets-its-cut-from-medicare-advantage/}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }

Full text

Collected · Record updated